Lu Han

Lu Han

Auto-generated profile, based on publicly available information

Lu Han

Medical University of South Carolina 1 Department of Biochemistry & Molecular Biology Charleston, South Carolina

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LHLu Han
Lu Han
YWYongxia Wu
Yongxia Wu
KFKun Fang
Kun Fang
Sean Patrick SweeneySean Patrick Sweeney
Sean Patrick Sweeney
URUlyss K. Roesner
Ulyss K. Roesner
GLGustavo Leone
Gustavo Leone
Pancreatic cancer is characterized by abundant desmoplasia, a dense stroma composed of extra-cellular and cellular components, with cancer associated fibroblasts (CAFs) being the major cellular component. However, the tissue(s) of origin for CAFs remains controversial. Here we determine the tissue origin of pancreatic CAFs through comprehensive lineage tracing studies in mice. We find that the splanchnic mesenchyme, the fetal cell layer surrounding the endoderm from which the pancreatic epithelium originates, gives rise to the majority of resident fibroblasts in the normal pancreas. In a genetic mouse model of pancreatic cancer, resident fibroblasts expand and constitute the bulk of CAFs. Single cell RNA profiling identifies gene expression signatures that are shared among the fetal splanchnic mesenchyme, adult fibroblasts and CAFs, suggesting a persistent transcriptional program underlies splanchnic lineage differentiation. Together, this study defines the phylogeny of the mesenchymal component of the pancreas and provides insights into pancreatic morphogenesis and tumorigenesis.

27 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LHLu Han
Lu Han
PCPraneet Chaturvedi
Praneet Chaturvedi
KKKeishi Kishimoto
Keishi Kishimoto
HKHiroyuki Koike
Hiroyuki Koike
TNTalia Nasr
Talia Nasr
AZAaron M. Zorn
Aaron M. Zorn
Visceral organs, such as the lungs, stomach and liver, are derived from the fetal foregut through a series of inductive interactions between the definitive endoderm (DE) and the surrounding splanchnic mesoderm (SM). While DE patterning is fairly well studied, the paracrine signaling controlling SM regionalization and how this is coordinated with epithelial identity is obscure. Here, we use single cell transcriptomics to generate a high-resolution cell state map of the embryonic mouse foregut. This identifies a diversity of SM cell types that develop in close register with the organ-specific epithelium. We infer a spatiotemporal signaling network of endoderm-mesoderm interactions that orchestrate foregut organogenesis. We validate key predictions with mouse genetics, showing the importance of endoderm-derived signals in mesoderm patterning. Finally, leveraging these signaling interactions, we generate different SM subtypes from human pluripotent stem cells (hPSCs), which previously have been elusive. The single cell data can be explored at: https://research.cchmc.org/ZornLab-singlecell.

13 January 2026 in Cancer Research
Verified
Journal Article
Open access
RBRachel Abigail Burge
Rachel Abigail Burge
OROzgun Le Roux
Ozgun Le Roux
OPOlesja Popow
Olesja Popow
VSVictoria K. Spadafora
Victoria K. Spadafora
CRChristabelle Rajesh
Christabelle Rajesh
GHGuy Aaron Hobbs
Guy Aaron Hobbs
Patients with pancreatic ductal adenocarcinoma (PDAC) harboring KRASG12R mutations have increased overall survival relative to patients with KRASG12D/V mutations. To investigate the mechanisms underlying this differential outcome, we developed a genetically engineered mouse model (GEMM) harboring KrasG12R and Trp53R172H mutations (KrasLSL-G12R/+;Trp53LSL-R172H/+;p48Cre-ERTM). Unlike KrasG12D models, KrasG12R GEMMs exhibited limited tumorigenesis, with only 10% developing pancreatic tumors after 1 year. Additionally, mice harboring whole-body expression of KrasG12R remained healthy for over 1 year, whereas KrasG12D mice developed rapid multifocal disease. Comparison of KRAS mutant-selective transcription and signaling in murine and human PDAC cell lines, GEMMs, and patient-derived xenograft (PDX) mouse models revealed that direct KRAS-mediated PI3K activation is necessary for robust tumor initiation in GEMMs. Unexpectedly, KRAS was not the primary driver of PI3K activity in human PDAC cell lines and PDX models, regardless of KRAS mutation. KRASG12R and KRASG12D activated a similar pancreas-specific transcriptional network, but KRASG12R promoted these pathways less robustly due to limited ERK/MAPK nuclear translocation. Finally, KRASG12R human pancreatic tumors had an altered tumor microenvironment (TME) with reduced collagen deposition and metastatic liver invasion. Together, this study demonstrated that KRASG12R is capable of driving tumorigenesis despite the reduced ERK/MAPK nuclear translocation and transcriptional output. Although human KRASG12D- and KRASG12R-mutant tumors display unexpected similarities in PI3K activity, the differential ERK/MAPK signaling activity and the extrinsic consequences on the TME provide support for using KRASG12R mutation status as a prognostic biomarker for therapeutic strategies. Significance: KRASG12R-mutant pancreatic cancer is characterized by lower ERK/MAPK nuclear translocation and transcriptional output than KRASG12D-mutant tumors, offering a potential window for patients with KRASG12R mutations to derive additional benefit from neoadjuvant therapy. See related commentary by Tiriac and Engle, p. 1817 See related article by Burge et al., p. 1854 See related article by Kamgar et al., p. 2042

17 June 2026
Verified
Other
Open access
RBRachel Abigail Burge
Rachel Abigail Burge
OROzgun Le Roux
Ozgun Le Roux
OPOlesja Popow
Olesja Popow
VSVictoria K. Spadafora
Victoria K. Spadafora
CRChristabelle Rajesh
Christabelle Rajesh
GHGuy Aaron Hobbs
Guy Aaron Hobbs
KrasLSL-G12R/+ induced pancreatic hyperplasia and vacuole formation with limited tumor development after 1 year. A, Graph showing the percentage of KP48 mice that developed pancreatic tumors. The number of mice (n) is indicated above each corresponding bar. B, Box plot of terminal body weights of male mice that were sacrificed at the determined endpoint and had tissues harvested. KDP48 mice (n = 6), KRP48 mice (n = 6), and control mice (n = 6). Female mice followed similar trends. Data are presented as mean weight at endpoint with no statistically significant differences in body weight. C, Box plot of pancreas weights normalized to total mouse weight at the time of sacrifice. KDP48 mice had significantly larger pancreata in comparison with control and KRP48 mice. P values were determined using one-way ANOVA with Tukey multiple comparison test. ****, P < 0.0001. D, Representative gross images of the pancreas. KRP48 (no tumor) has an increase in islet cells (H&E 1) and proliferation of ductal epithelial cells (H&E 2, black arrow). Both KDP48 (tumor-bearing) and KRP48 (tumor-bearing) mice show increased periductal fibrosis. Representative immunostains for CK19 (ductal marker), αSMA (fibroblast), Ki-67 (proliferation), and Alcian blue–periodic acid-Schiff (AB-PAS) stain (glycogen and zymogen granules). H&E images were analyzed by a veterinary pathologist. Scale bar, 50 μm.

17 June 2026
Verified
Other
Open access
RBRachel Abigail Burge
Rachel Abigail Burge
OROzgun Le Roux
Ozgun Le Roux
OPOlesja Popow
Olesja Popow
VSVictoria K. Spadafora
Victoria K. Spadafora
CRChristabelle Rajesh
Christabelle Rajesh
GHGuy Aaron Hobbs
Guy Aaron Hobbs
Engineering a KrasLSL-G12R/+ murine model.